MAS1L and triple-A syndrome: And activation of the Ang‐(1–7)/MasR axis may effectively mitigate vascular injury and lesions associated with Ang II/AT1R, especially AAA and risk factors associated with AAA, such as endothelial dysfunction and atherosclerosis.